Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Nov;113(3):781–788. doi: 10.1111/j.1476-5381.1994.tb17061.x

Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.

P Kotsonis 1, H Majewski 1
PMCID: PMC1510434  PMID: 7858867

Abstract

1. The effects of the beta 2-adrenoceptor agonist, procaterol, on sympathetic neuroeffector transmission were studied in the pithed adrenal demedullated rat to determine if generation of angiotensin II was involved in its effect. Pressor responses were elicited by either electrical stimulation (20 V, 2 Hz) of the entire spinal sympathetic outflow or methoxamine (0.1 mg kg-1, i.v.). 2. Sodium nitroprusside (3 and 5 micrograms kg-1 min-1, i.v.) produced hypotension and the pressor responses to both sympathetic nerve stimulation and methoxamine were reduced. This indicates that decreasing blood pressure in pithed rats reduces pressor responses. Procaterol (10 and 30 ng kg-1 min-1, i.v.) also produced hypotension but did not alter pressor responses to sympathetic nerve stimulation. Nevertheless, procaterol (10 and 30 ng kg-1 min-1, i.v.) did reduce pressor responses to to methoxamine. Together these results suggest that procaterol may have enhanced sympathetic neurotransmitter release. This was confirmed in another series of experiments where procaterol (30 ng kg-1 min-1, i.v.) increased plasma noradrenaline levels during sympathetic nerve stimulation. 3. Captopril (5 mg kg-1, i.v.) produced hypotension and as expected reduced pressor responses to sympathetic nerve stimulation. When the hypotensive effect of captopril was abolished by concomitant vasopressin infusion (1.5-4.5 i mu kg-1 min-1, i.v.), pressor responses to sympathetic nerve stimulation were restored to pre-captopril levels. (ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borkowski K. R. Pre- and postjunctional beta-adrenoreceptors and hypertension. J Auton Pharmacol. 1988 Jun;8(2):153–171. doi: 10.1111/j.1474-8673.1988.tb00179.x. [DOI] [PubMed] [Google Scholar]
  2. Borkowski K. R., Quinn P. Facilitation by beta-adrenoreceptors of stimulation-induced vasoconstriction in pithed spontaneously hypertensive rats. J Auton Pharmacol. 1984 Jun;4(2):127–131. doi: 10.1111/j.1474-8673.1984.tb00089.x. [DOI] [PubMed] [Google Scholar]
  3. Boura A. L., Hui S. C., Rechtman M. P., Walters W. A. Captopril inhibits pressor responses to peripheral sympathetic nerve activation in cats and rats. Clin Exp Pharmacol Physiol Suppl. 1982;7:123–128. [PubMed] [Google Scholar]
  4. Clough D. P., Collis M. G., Conway J., Hatton R., Keddie J. R. Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. Am J Cardiol. 1982 Apr 21;49(6):1410–1414. doi: 10.1016/0002-9149(82)90352-6. [DOI] [PubMed] [Google Scholar]
  5. Coppes R. P., Smit J., Khali N. N., Brouwer F., Zaagsma J. Strong activation of vascular prejunctional beta 2-adrenoceptors in freely moving rats by adrenaline released as a co-transmitter. Eur J Pharmacol. 1993 Oct 26;243(3):273–279. doi: 10.1016/0014-2999(93)90185-k. [DOI] [PubMed] [Google Scholar]
  6. Cryer P. E., Rizza R. A., Haymond M. W., Gerich J. E. Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man. Metabolism. 1980 Nov;29(11 Suppl 1):1114–1118. doi: 10.1016/0026-0495(80)90019-0. [DOI] [PubMed] [Google Scholar]
  7. Draper A. J., Meghji S., Redfern P. H. Enhanced presynaptic facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats. J Auton Pharmacol. 1989 Apr;9(2):103–111. doi: 10.1111/j.1474-8673.1989.tb00201.x. [DOI] [PubMed] [Google Scholar]
  8. Floras J. S. Epinephrine and the genesis of hypertension. Hypertension. 1992 Jan;19(1):1–18. doi: 10.1161/01.hyp.19.1.1. [DOI] [PubMed] [Google Scholar]
  9. Göthert M., Kollecker P. Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis. Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):156–165. doi: 10.1007/BF00505816. [DOI] [PubMed] [Google Scholar]
  10. Hatton R., Clough D. P. Captopril interferes with neurogenic vasoconstriction in the pithed rat by angiotensin-dependent mechanisms. J Cardiovasc Pharmacol. 1982 Jan-Feb;4(1):116–123. doi: 10.1097/00005344-198201000-00019. [DOI] [PubMed] [Google Scholar]
  11. Johnson E. M., Jr, Marshall G. R., Needleman P. Modification of responses to sympathetic nerve stimulation by the renin-angiotensin system in rats. Br J Pharmacol. 1974 Aug;51(4):541–547. doi: 10.1111/j.1476-5381.1974.tb09672.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kawasaki H., Cline W. H., Jr, Su C. Involvement of the vascular renin-angiotensin system in beta adrenergic receptor-mediated facilitation of vascular neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther. 1984 Oct;231(1):23–32. [PubMed] [Google Scholar]
  13. Li C. G., Majewski H., Rand M. J. Facilitation of noradrenaline release from sympathetic nerves in rat anococcygeus muscle by activation of prejunctional beta-adrenoceptors and angiotensin receptors. Br J Pharmacol. 1988 Oct;95(2):385–392. doi: 10.1111/j.1476-5381.1988.tb11657.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Majewski H., Hedler L., Schurr C., Starke K. Dual effect of adrenaline on noradrenaline release in the pithed rabbit. J Cardiovasc Pharmacol. 1985 Mar-Apr;7(2):251–257. doi: 10.1097/00005344-198503000-00007. [DOI] [PubMed] [Google Scholar]
  15. Majewski H., Hedler L., Starke K. The noradrenaline rate in the anaesthetized rabbit: facilitation by adrenaline. Naunyn Schmiedebergs Arch Pharmacol. 1982 Oct;321(1):20–27. doi: 10.1007/BF00586343. [DOI] [PubMed] [Google Scholar]
  16. Majewski H. Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors. J Auton Pharmacol. 1983 Mar;3(1):47–60. doi: 10.1111/j.1474-8673.1983.tb00496.x. [DOI] [PubMed] [Google Scholar]
  17. Majewski H., Murphy T. V. Beta-adrenoceptor blockade and sympathetic neurotransmission in the pithed rat. J Hypertens. 1989 Dec;7(12):991–996. doi: 10.1097/00004872-198912000-00010. [DOI] [PubMed] [Google Scholar]
  18. Majewski H., Rand M. J. A possible role of epinephrine in the development of hypertension. Med Res Rev. 1986 Oct-Dec;6(4):467–486. doi: 10.1002/med.2610060405. [DOI] [PubMed] [Google Scholar]
  19. Majewski H., Rand M. J., Tung L. H. Activation of prejunctional beta-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter. Br J Pharmacol. 1981 Jul;73(3):669–679. doi: 10.1111/j.1476-5381.1981.tb16802.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mian M. A., Majewski H., Rand M. J. Facilitation of noradrenaline release by isoprenaline in rat isolated atria does not involve angiotensin II formation. Clin Exp Pharmacol Physiol. 1989 Dec;16(12):905–911. doi: 10.1111/j.1440-1681.1989.tb02401.x. [DOI] [PubMed] [Google Scholar]
  21. Nakamaru M., Jackson E. K., Inagami T. Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am J Physiol. 1986 Jan;250(1 Pt 2):H144–H148. doi: 10.1152/ajpheart.1986.250.1.H144. [DOI] [PubMed] [Google Scholar]
  22. Rajanayagam M. A., Musgrave I. F., Rand M. J., Majewski H. Facilitation of noradrenaline release by isoprenaline is not mediated by angiotensin II in mouse atria and rat tail artery. Arch Int Pharmacodyn Ther. 1989 May-Jun;299:185–199. [PubMed] [Google Scholar]
  23. Rechtman M., Majewski H. A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig. Br J Pharmacol. 1993 Sep;110(1):289–296. doi: 10.1111/j.1476-5381.1993.tb13807.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rump L. C., Majewski H. Beta adrenoceptor facilitation of norepinephrine release is not dependent on local angiotensin II formation in the rat isolated kidney. J Pharmacol Exp Ther. 1987 Dec;243(3):1107–1112. [PubMed] [Google Scholar]
  25. Schlicker E., Erkens K., Göthert M. Probable involvement of vascular angiotensin II formation in the beta 2-adrenoceptor-mediated facilitation of the neurogenic vasopressor response in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):536–542. doi: 10.1007/BF00179326. [DOI] [PubMed] [Google Scholar]
  26. Schmidt H. H., Schurr C., Hedler L., Majewski H. Local modulation of noradrenaline release in vivo: presynaptic beta 2-adrenoceptors and endogenous adrenaline. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):641–649. doi: 10.1097/00005344-198407000-00014. [DOI] [PubMed] [Google Scholar]
  27. Share L. Role of vasopressin in cardiovascular regulation. Physiol Rev. 1988 Oct;68(4):1248–1284. doi: 10.1152/physrev.1988.68.4.1248. [DOI] [PubMed] [Google Scholar]
  28. Stj-5aarne L., Brundin J. Dual adreoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves: facilitation by BETA-receptors and inhibitor by alpha-receptors. Acta Physiol Scand. 1975 May;94(1):139–141. doi: 10.1111/j.1748-1716.1975.tb05872.x. [DOI] [PubMed] [Google Scholar]
  29. Waldman S. A., Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987 Sep;39(3):163–196. [PubMed] [Google Scholar]
  30. Weinstock M., Thoa N. B., Kopin I. J. Beta-adrenoceptors modulate noradrenaline release from axonal sprouts in cultured rat superior cervical ganglia. Eur J Pharmacol. 1978 Feb 1;47(3):297–302. doi: 10.1016/0014-2999(78)90237-6. [DOI] [PubMed] [Google Scholar]
  31. Zimmerman B. G. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci (Lond) 1981 Apr;60(4):343–348. doi: 10.1042/cs0600343. [DOI] [PubMed] [Google Scholar]
  32. Ziogas J., Story D. F. Angiotensin II generation in the rat vena cava: stimulation of local synthesis by beta-adrenoceptor activation. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jan;343(1):31–36. doi: 10.1007/BF00180673. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES